MTOR and neoplasm: Besides, DRAIC stimulates AMPK and can prevent the phosphorylation of key substrates by mTORC1 [51], thereby providing a therapeutic approach for the AMPK–mTOR pathway regulation of tumor-induced cachexia muscle atrophy.